NORD Top Banner Oct 9-11

Cancers

Aug 3, 2020| Posted in: Autoimmune / Autoinflammatory Disorders, Cancers, Lung Diseases, News

COVID-19 and Lung Cancer Patients

Ross Camidge, MD, PhD of the University of…
Jul 31, 2020| Posted in: Cancers, Drug Development, Hematologic Disorders, News

Promising Phase 2 Trial Results for Patients With Myelodysplastic Syndrome and AML

Jennifer Elliott, PhD, Global Project Leader at Takeda…
Jul 30, 2020| Posted in: Cancers, Hematologic Disorders, Treatment

Typical Treatment Plan for Polycythemia Vera Patients

Ronald Hoffman, MD, Director of the Myeloproliferative Diseases…
Jul 25, 2020| Posted in: Cancers, Hematologic Disorders, News, Regulations, Treatment

FDA Approves CAR T Therapy for Mantle Cell Lymphoma

The U.S. Food and Drug Administration (FDA) has…
Jul 22, 2020| Posted in: Advocacy, Cancers, Diagnosis, Hematologic Disorders

Lymphoma Research Foundation Overview

Meghan Gutierrez, chief executive officer of the Lymphoma…
Jul 17, 2020| Posted in: Cancers, Drug Development, Hematologic Disorders, Treatment

Follicular Lymphoma: Diagnosis, Prognosis, and Treatment

John Leonard, MD of Weill Cornell Medicine discusses…
Jul 13, 2020| Posted in: Cancers, Drug Development, Ophthalmology/Eye Diseases

Combination FAK and RAF-MEK Inhibitors Showing Promise as a Uveal Melanoma Treatment

Silvio Gutkind, PhD of University of California San…
Jul 10, 2020| Posted in: Cancers, Drug Development, Hematologic Disorders, Treatment

Real Data on Efficacy of Transitioning to Ixazomib-Based Treatment for Multiple Myeloma

Steve Noga, MD, of Takeda Oncology discusses the…
Jul 7, 2020| Posted in: Cancers, Hematologic Disorders, News, Treatment

Accelerated Approval of Tazemetostat for Follicular Lymphoma

John Leonard, MD of Weill Cornell Medicine discusses…
Jul 6, 2020| Posted in: Cancers, Endocrine Disorders, Metabolic Disorders, Regulations, Treatment

New Oral Octreotide Approved to Treat Acromegaly

Susan Samson, MD, PhD, of Baylor College of…

Tenosynovial Giant Cell Tumor (TGCT)

Tenosynovial giant cell tumor (TGCT) is a non-malignant tumor involving the joint synovium, bursae, and tendon sheath. These rare tumors are sometimes referred to as giant cell tumor of the tendon sheath (GCT-TS) and/or pigmented villonodular synovitis (PVNS).

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.
  • Heather Lau, MD, MS, NYU School of Medicine, New York, NY
  • Morie A Gertz, MD, Mayo Clinic, Rochester, MN
  • Timothy Craig, DO, Penn State University, Hershey, PA
  • Eric T. Wong, MD, Harvard Medical School, Boston, MA

Cancers

Topics

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.